Kathrin Scherer Hofmeier Selected Research

Kathrin Scherer Hofmeier Research Topics

5	Hypersensitivity (Allergy) 12/2021 - 01/2014
3	Contact Dermatitis (Eczema, Contact) 12/2021 - 06/2013
2	Allergic Contact Dermatitis 01/2021 - 06/2013
2	Anaphylaxis (Anaphylactic Shock) 02/2017 - 01/2014
1	Acute Kidney Injury (Acute Renal Failure) 02/2019
1	Infections 02/2019
1	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 02/2019
1	Anemia 02/2019
1	Acute Liver Failure (Fulminant Hepatic Failure) 02/2019
1	Pulmonary Tuberculosis 02/2019
1	Urticaria (Hives) 02/2018
1	Chronic Urticaria 02/2018
1	Food Hypersensitivity (Food Allergy) 02/2017
1	Tick Bites 02/2017
1	Meningomyelocele (Myelomeningocele) 01/2014
1	Irritant Dermatitis 06/2013
1	Hypopigmentation (Hypomelanosis) 06/2013

2	Irritants (Vesicants)IBA 01/2021 - 06/2013
2	Omalizumab (Xolair)FDA Link 02/2018 - 01/2014
1	Ointments (Pastes)IBA 12/2021
1	Hair Preparations (Cosmetics, Hair)IBA 12/2021
1	Disinfectants (Biocides)IBA 01/2021
1	Pharmaceutical PreparationsIBA 02/2019
1	SteroidsIBA 02/2019
1	Rifampin (Rifampicin)FDA LinkGeneric 02/2019
1	Histamine H1 AntagonistsIBA 02/2018
1	anti-IgE antibodiesIBA 02/2018
1	AllergensIBA 02/2017
1	Cetuximab (Erbitux)FDA Link 02/2017
1	CarbohydratesIBA 02/2017
1	Immunoglobulin E (IgE)IBA 02/2017
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2015
1	Glycoproteins (Glycoprotein)IBA 01/2015
1	AntithrombinsIBA 01/2015
1	AnticoagulantsIBA 01/2015
1	Factor Xa InhibitorsIBA 01/2015
1	Ethylene Oxide (Oxirane)IBA 01/2014
1	4-phenylenediamine (p-phenylenediamine)FDA Link 06/2013
1	Coloring Agents (Dyes)IBA 06/2013

1	Hip Prosthesis 02/2019
1	Therapeutics 02/2018
1	Renal Dialysis (Hemodialysis) 01/2014
1	General Anesthesia 01/2014
1	Tattooing 06/2013